Literature DB >> 15448325

Drug delivery into the eye with the use of ultrasound.

Vesna Zderic1, John I Clark, Shahram Vaezy.   

Abstract

OBJECTIVE: To evaluate ultrasound enhancement of drug delivery through the cornea and the histologic appearance of the cornea up to 24 hours after treatment.
METHODS: Corneas were exposed to ultrasound at a frequency of 880 kHz and intensities of 0.19 to 0.56 W/cm2 (continuous mode) with an exposure duration of 5 minutes. The aqueous humor concentration of a topically applied hydrophilic dye, sodium fluorescein, was determined quantitatively in ultrasound- and sham-treated rabbit eyes in vivo. Gross and light microscopic examinations were used to observe structural changes in the cornea 0 to 24 hours after ultrasound exposure. Cavitation activity was measured with a passive cavitation detector.
RESULTS: Most cells with an appearance different from that of the normal cells were present in the surface layer of the corneal epithelium. No structural changes were observed in the stroma. The increase in dye concentration in the aqueous humor (relative to sham treatment), after the simultaneous application of ultrasound and the dye solution, was 2.4 times at 0.19 W/cm2, 3.8 times at 0.34 W/cm2, and 10.6 times at 0.56 W/cm2 (P <.05). Dye delivery was found to increase with increasing ultrasound intensity, which corresponded to an increase in cavitation activity. Corneal pits, observed in the ultrasound-treated epithelium, completely disappeared within 90 minutes.
CONCLUSIONS: Application of 880-kHz ultrasound provided up to 10-fold enhancement in the delivery of a hydrophilic compound through the cornea while producing minor changes in the corneal epithelium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448325     DOI: 10.7863/jum.2004.23.10.1349

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  14 in total

1.  Thermal safety of ultrasound-enhanced ocular drug delivery: A modeling study.

Authors:  Marjan Nabili; Craig Geist; Vesna Zderic
Journal:  Med Phys       Date:  2015-10       Impact factor: 4.071

2.  Can ultrasound solve the transport barrier of the neural retina?

Authors:  Liesbeth Peeters; Ine Lentacker; Roosmarijn E Vandenbroucke; Bart Lucas; Joseph Demeester; Niek N Sanders; Stefaan C De Smedt
Journal:  Pharm Res       Date:  2008-07-23       Impact factor: 4.200

3.  Ultrasound-enhanced penetration of topical riboflavin into the corneal stroma.

Authors:  Ricardo Lamy; Elliot Chan; Hui Zhang; Vasant A Salgaonkar; Sam D Good; Travis C Porco; Chris J Diederich; Jay M Stewart
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-28       Impact factor: 4.799

4.  Model for Porosity Changes Occurring during Ultrasound-Enhanced Transcorneal Drug Delivery.

Authors:  Prasanna Hariharan; Marjan Nabili; Allan Guan; Vesna Zderic; Matthew Myers
Journal:  Ultrasound Med Biol       Date:  2017-03-21       Impact factor: 2.998

5.  Fetal membrane transport enhancement using ultrasound for drug delivery and noninvasive detection.

Authors:  Lior Wolloch; Aharon Azagury; Riki Goldbart; Tamar Traitel; Gabriel Groisman; Mordechai Hallak; Joseph Kost
Journal:  Pharm Res       Date:  2014-07-31       Impact factor: 4.200

Review 6.  Getting Drugs Across Biological Barriers.

Authors:  Rong Yang; Tuo Wei; Hannah Goldberg; Weiping Wang; Kathleen Cullion; Daniel S Kohane
Journal:  Adv Mater       Date:  2017-07-28       Impact factor: 30.849

7.  Ultrasound Stimulation of Insulin Release from Pancreatic Beta Cells as a Potential Novel Treatment for Type 2 Diabetes.

Authors:  Ivan Suarez Castellanos; Aleksandar Jeremic; Joshua Cohen; Vesna Zderic
Journal:  Ultrasound Med Biol       Date:  2017-03-25       Impact factor: 2.998

8.  Ultrasound-enhanced delivery of antibiotics and anti-inflammatory drugs into the eye.

Authors:  Marjan Nabili; Hetal Patel; Sankaranarayana P Mahesh; Ji Liu; Craig Geist; Vesna Zderic
Journal:  Ultrasound Med Biol       Date:  2013-02-13       Impact factor: 2.998

9.  Drug delivery to the posterior segment of the eye for pharmacologic therapy.

Authors:  Shalin S Shah; Lori Vidal Denham; Jasmine R Elison; Partha S Bhattacharjee; Christian Clement; Tashfin Huq; James M Hill
Journal:  Expert Rev Ophthalmol       Date:  2010-02-01

Review 10.  Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications.

Authors:  Blake A Booth; Lori Vidal Denham; Saadallah Bouhanik; Jean T Jacob; James M Hill
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.